title: Cost analysis of schizophrenia treatment with second-generation antipsychotic medications in North Carolina's Medicaid program.
authors.affiliation: Department of Health Economics and Management, Peking University Guanghua School of Management, Beijing, China.
authors.forename: Gordon G
authors.initials: GG
authors.lastname: Liu
authors.forename: Shawn X
authors.initials: SX
authors.lastname: Sun
authors.forename: Dale B
authors.initials: DB
authors.lastname: Christensen
authors.forename: Zhongyun
authors.initials: Z
authors.lastname: Zhao
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000191:economics* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000191:economics / Q000627:therapeutic use; D017281:Cost of Illness; D003365:Costs and Cost Analysis; D016208:Databases, Factual; D005260:Female; D006801:Humans; D008297:Male; D008484:Medicaid / Q000191:economics*; D008875:Middle Aged; D009657:North Carolina; D000077152:Olanzapine; D018967:Risperidone / Q000191:economics / Q000627:therapeutic use; D012559:Schizophrenia / Q000191:economics* / Q000628:therapy*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine